LEFKOFF KYLE 4
4 · ARRAY BIOPHARMA INC · Filed Oct 29, 2018
Insider Transaction Report
Form 4
LEFKOFF KYLE
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-10-25+25,000→ 25,000 totalExercise: $14.55Exp: 2028-10-25→ Common Stock (25,000 underlying) - Exercise/Conversion
Restricted Stock Units
2018-10-26−5,000→ 0 totalExercise: $0.00→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2018-10-26+5,000→ 22,720 total - Award
Restricted Stock Units
2018-10-25+5,000→ 5,000 totalExercise: $0.00→ Common Stock (5,000 underlying)
Holdings
- 45,000(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by Array BioPharma Inc. ("Array") on October 26, 2017, as a result of the vesting of all such RSUs.
- [F2]Comprised of 30,000 shares of common stock in trust for the benefit of Mr. Lefkoff's minor children and 15,000 shares of common stock held by BV Partners III Profit Sharing account for the benefit of Mr. Lefkoff.
- [F3]The options vest in full on October 25, 2019, subject to continued service on Array's board of directors.
- [F4]RSUs awarded to the reporting person for no additional cash consideration and each represents a contingent right to receive one share of common stock. The RSUs vest in full and will be settled in common stock on October 25, 2019, subject to continued service on Array's board of directors.
- [F5]The RSUs vested and were settled in common stock on October 26, 2018.